▶ 調査レポート

CXCR4拮抗薬の世界市場:市場規模・現状・予測

• 英文タイトル:Global CXCR4 Antagonists Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。CXCR4拮抗薬の世界市場:市場規模・現状・予測 / Global CXCR4 Antagonists Market Size, Status and Forecast 2019-2025 / QYR9ST04430資料のイメージです。• レポートコード:QYR9ST04430
• 出版社/出版日:QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、93ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※当調査レポートでは、CXCR4拮抗薬の世界市場について調査・分析し、CXCR4拮抗薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(BL-8040、GMI-1359、プレリキサホル(AMD3100)、バリキサフォート(POL6326)、USL311、その他)、用途別(がん、HIV、慢性炎症性疾患)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界のCXCR4拮抗薬市場動向
・主要企業別マーケットシェア
・CXCR4拮抗薬の種類別市場規模2014-2019
(BL-8040、GMI-1359、プレリキサホル(AMD3100)、バリキサフォート(POL6326)、USL311、その他)
・CXCR4拮抗薬の用途別市場規模2014-2019
(がん、HIV、慢性炎症性疾患)
・CXCR4拮抗薬の北米市場:主要企業・種類別/用途別市場規模
・CXCR4拮抗薬のヨーロッパ市場:主要企業・種類別/用途別市場規模
・CXCR4拮抗薬の中国市場:主要企業・種類別/用途別市場規模
・CXCR4拮抗薬の日本国内市場:主要企業・種類別/用途別市場規模
・CXCR4拮抗薬の東南アジア市場:主要企業・種類別/用途別市場規模
・CXCR4拮抗薬のインド市場:主要企業・種類別/用途別市場規模
・CXCR4拮抗薬の中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(Sanofi、BioLineRx、X4 Pharmaceuticals、Eli Lilly、Roche、Merck、Biokine Therapeutics、GlycoMimetics、Harmonic Pharma、Upsher-Smith Laboratories)
・CXCR4拮抗薬の市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...

CXCR4 antagonists are small-molecule which block the CXCR4 receptors and prevent their activation. Blocking the receptors stop the receptors’ ligand, CXCL12, from binding which prevent downstream effects. CXCR4 antagonists are especially important for hindering cancer progression because one of the downstream effects initiated by CXCR4 receptor activation is cell movement which lead to tumor growth and metastasis in cancer patients. The CXCR4 receptor has been targeted by antagonistic substances, these antagonists have prospective use as therapeutic drug agents, and are currently under development in labs worldwide.In 2018, the global CXCR4 Antagonists market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global CXCR4 Antagonists status, future forecast, growth opportunity, key market and key players. The study objectives are to present the CXCR4 Antagonists development in United States, Europe and China.

The key players covered in this study
Sanofi
BioLineRx
X4 Pharmaceuticals
Eli Lilly
Roche
Merck
Biokine Therapeutics
GlycoMimetics
Harmonic Pharma
Upsher-Smith Laboratories

Market segment by Type, the product can be split into
BL-8040
GMI-1359
Plerixafor (AMD3100)
Balixafortide (POL6326)
USL311
Others

Market segment by Application, split into
Cancer
HIV
Chronic Inflammatory Diseases

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global CXCR4 Antagonists status, future forecast, growth opportunity, key market and key players.
To present the CXCR4 Antagonists development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of CXCR4 Antagonists are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global CXCR4 Antagonists Market Size Growth Rate by Type (2014-2025)
1.4.2 BL-8040
1.4.3 GMI-1359
1.4.4 Plerixafor (AMD3100)
1.4.5 Balixafortide (POL6326)
1.4.6 USL311
1.4.7 Others
1.5 Market by Application
1.5.1 Global CXCR4 Antagonists Market Share by Application (2014-2025)
1.5.2 Cancer
1.5.3 HIV
1.5.4 Chronic Inflammatory Diseases
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 CXCR4 Antagonists Market Size
2.2 CXCR4 Antagonists Growth Trends by Regions
2.2.1 CXCR4 Antagonists Market Size by Regions (2014-2025)
2.2.2 CXCR4 Antagonists Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 CXCR4 Antagonists Market Size by by Players
3.1.1 Global CXCR4 Antagonists Revenue by by Players (2014-2019)
3.1.2 Global CXCR4 Antagonists Revenue Market Share by by Players (2014-2019)
3.1.3 Global CXCR4 Antagonists Market Concentration Ratio (CR5 and HHI)
3.2 CXCR4 Antagonists Key Players Head office and Area Served
3.3 Key Players CXCR4 Antagonists Product/Solution/Service
3.4 Date of Enter into CXCR4 Antagonists Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global CXCR4 Antagonists Market Size by Type (2014-2019)
4.2 Global CXCR4 Antagonists Market Size by Application (2014-2019)

5 United States
5.1 United States CXCR4 Antagonists Market Size (2014-2019)
5.2 CXCR4 Antagonists Key Players in United States
5.3 United States CXCR4 Antagonists Market Size by Type
5.4 United States CXCR4 Antagonists Market Size by Application

6 Europe
6.1 Europe CXCR4 Antagonists Market Size (2014-2019)
6.2 CXCR4 Antagonists Key Players in Europe
6.3 Europe CXCR4 Antagonists Market Size by Type
6.4 Europe CXCR4 Antagonists Market Size by Application

7 China
7.1 China CXCR4 Antagonists Market Size (2014-2019)
7.2 CXCR4 Antagonists Key Players in China
7.3 China CXCR4 Antagonists Market Size by Type
7.4 China CXCR4 Antagonists Market Size by Application

8 Japan
8.1 Japan CXCR4 Antagonists Market Size (2014-2019)
8.2 CXCR4 Antagonists Key Players in Japan
8.3 Japan CXCR4 Antagonists Market Size by Type
8.4 Japan CXCR4 Antagonists Market Size by Application

9 Southeast Asia
9.1 Southeast Asia CXCR4 Antagonists Market Size (2014-2019)
9.2 CXCR4 Antagonists Key Players in Southeast Asia
9.3 Southeast Asia CXCR4 Antagonists Market Size by Type
9.4 Southeast Asia CXCR4 Antagonists Market Size by Application

10 India
10.1 India CXCR4 Antagonists Market Size (2014-2019)
10.2 CXCR4 Antagonists Key Players in India
10.3 India CXCR4 Antagonists Market Size by Type
10.4 India CXCR4 Antagonists Market Size by Application

11 Central & South America
11.1 Central & South America CXCR4 Antagonists Market Size (2014-2019)
11.2 CXCR4 Antagonists Key Players in Central & South America
11.3 Central & South America CXCR4 Antagonists Market Size by Type
11.4 Central & South America CXCR4 Antagonists Market Size by Application

12 International Players Profiles
12.1 Sanofi
12.1.1 Sanofi Company Details
12.1.2 Company Description and Business Overview
12.1.3 CXCR4 Antagonists Introduction
12.1.4 Sanofi Revenue in CXCR4 Antagonists Business (2014-2019)
12.1.5 Sanofi Recent Development
12.2 BioLineRx
12.2.1 BioLineRx Company Details
12.2.2 Company Description and Business Overview
12.2.3 CXCR4 Antagonists Introduction
12.2.4 BioLineRx Revenue in CXCR4 Antagonists Business (2014-2019)
12.2.5 BioLineRx Recent Development
12.3 X4 Pharmaceuticals
12.3.1 X4 Pharmaceuticals Company Details
12.3.2 Company Description and Business Overview
12.3.3 CXCR4 Antagonists Introduction
12.3.4 X4 Pharmaceuticals Revenue in CXCR4 Antagonists Business (2014-2019)
12.3.5 X4 Pharmaceuticals Recent Development
12.4 Eli Lilly
12.4.1 Eli Lilly Company Details
12.4.2 Company Description and Business Overview
12.4.3 CXCR4 Antagonists Introduction
12.4.4 Eli Lilly Revenue in CXCR4 Antagonists Business (2014-2019)
12.4.5 Eli Lilly Recent Development
12.5 Roche
12.5.1 Roche Company Details
12.5.2 Company Description and Business Overview
12.5.3 CXCR4 Antagonists Introduction
12.5.4 Roche Revenue in CXCR4 Antagonists Business (2014-2019)
12.5.5 Roche Recent Development
12.6 Merck
12.6.1 Merck Company Details
12.6.2 Company Description and Business Overview
12.6.3 CXCR4 Antagonists Introduction
12.6.4 Merck Revenue in CXCR4 Antagonists Business (2014-2019)
12.6.5 Merck Recent Development
12.7 Biokine Therapeutics
12.7.1 Biokine Therapeutics Company Details
12.7.2 Company Description and Business Overview
12.7.3 CXCR4 Antagonists Introduction
12.7.4 Biokine Therapeutics Revenue in CXCR4 Antagonists Business (2014-2019)
12.7.5 Biokine Therapeutics Recent Development
12.8 GlycoMimetics
12.8.1 GlycoMimetics Company Details
12.8.2 Company Description and Business Overview
12.8.3 CXCR4 Antagonists Introduction
12.8.4 GlycoMimetics Revenue in CXCR4 Antagonists Business (2014-2019)
12.8.5 GlycoMimetics Recent Development
12.9 Harmonic Pharma
12.9.1 Harmonic Pharma Company Details
12.9.2 Company Description and Business Overview
12.9.3 CXCR4 Antagonists Introduction
12.9.4 Harmonic Pharma Revenue in CXCR4 Antagonists Business (2014-2019)
12.9.5 Harmonic Pharma Recent Development
12.10 Upsher-Smith Laboratories
12.10.1 Upsher-Smith Laboratories Company Details
12.10.2 Company Description and Business Overview
12.10.3 CXCR4 Antagonists Introduction
12.10.4 Upsher-Smith Laboratories Revenue in CXCR4 Antagonists Business (2014-2019)
12.10.5 Upsher-Smith Laboratories Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table CXCR4 Antagonists Key Market Segments
Table Key Players CXCR4 Antagonists Covered
Table Global CXCR4 Antagonists Market Size Growth Rate by Type 2019-2025 (Million US$)
Figure Global CXCR4 Antagonists Market Share by TypeType in 2018 & 2025
Figure BL-8040 Figures
Table Key Players of BL-8040
Figure GMI-1359 Figures
Table Key Players of GMI-1359
Figure Plerixafor (AMD3100) Figures
Table Key Players of Plerixafor (AMD3100)
Figure Balixafortide (POL6326) Figures
Table Key Players of Balixafortide (POL6326)
Figure USL311 Figures
Table Key Players of USL311
Figure Others Figures
Table Key Players of Others
Table Global CXCR4 Antagonists Market Size Growth by Application 2019-2025 (Million US$)
Figure Global CXCR4 Antagonists Market Share by Application in 2018 & 2025
Figure Cancer Case Studies
Figure HIV Case Studies
Figure Chronic Inflammatory Diseases Case Studies
Figure CXCR4 Antagonists Report Years Considered
Table Global CXCR4 Antagonists Market Size 2014-2025 (Million US$)
Figure Global CXCR4 Antagonists Market Size and Growth Rate 2014-2025 (Million US$)
Table Global CXCR4 Antagonists Market Size by Regions 2019-2025 (Million US$)
Table Global CXCR4 Antagonists Market Size by Regions 2019-2025 (Million US$)
Table Global CXCR4 Antagonists Market Share by Regions 2014-2019
Figure Global CXCR4 Antagonists Market Share by Regions 2014-2019
Figure Global CXCR4 Antagonists Market Share by Regions 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global CXCR4 Antagonists Revenue by by Players (2014-2019) (Million US$)
Table Global CXCR4 Antagonists Market Share by by Players (2014-2019)
Figure Global CXCR4 Antagonists Market Share by by Players in 2018
Table Global CXCR4 Antagonists by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players CXCR4 Antagonists Product/Solution/Service
Table Date of Enter into CXCR4 Antagonists Market
Table Mergers & Acquisitions, Expansion Plans
Table Global CXCR4 Antagonists Market Size by Type (2014-2019) (Million US$)
Table Global CXCR4 Antagonists Market Size Share by Type (2014-2019)
Figure Global CXCR4 Antagonists Market Size Market Share by Type (2014-2019)
Table Global CXCR4 Antagonists Market Size by Application (2014-2019) (Million US$)
Table Global CXCR4 Antagonists Market Size Share by Application (2014-2019)
Figure Global CXCR4 Antagonists Market Size Market Share by Application (2014-2019)
Figure Global CXCR4 Antagonists Revenue Market Share by Application in 2018
Figure United States CXCR4 Antagonists Market Size 2014-2019 (Million US$)
Table United States Key Players CXCR4 Antagonists Revenue (2018-2019) (Million US$)
Table United States Key Players CXCR4 Antagonists Market Share (2018-2019)
Table United States CXCR4 Antagonists Market Size by Type (2014-2019) (Million US$)
Table United States CXCR4 Antagonists Market Share by Type (2014-2019)
Table United States CXCR4 Antagonists Market Size by Application (2014-2019) (Million US$)
Table United States CXCR4 Antagonists Market Share by Application (2014-2019)
Figure Europe CXCR4 Antagonists Market Size 2014-2019 (Million US$)
Table Europe Key Players CXCR4 Antagonists Revenue (2018-2019) (Million US$)
Table Europe Key Players CXCR4 Antagonists Market Share (2018-2019)
Table Europe CXCR4 Antagonists Market Size by Type (2014-2019) (Million US$)
Table Europe CXCR4 Antagonists Market Share by Type (2014-2019)
Table Europe CXCR4 Antagonists Market Size by Application (2014-2019) (Million US$)
Table Europe CXCR4 Antagonists Market Share by Application (2014-2019)
Figure China CXCR4 Antagonists Market Size 2014-2019 (Million US$)
Table China Key Players CXCR4 Antagonists Revenue (2018-2019) (Million US$)
Table China Key Players CXCR4 Antagonists Market Share (2018-2019)
Table China CXCR4 Antagonists Market Size by Type (2014-2019) (Million US$)
Table China CXCR4 Antagonists Market Share by Type (2014-2019)
Table China CXCR4 Antagonists Market Size by Application (2014-2019) (Million US$)
Table China CXCR4 Antagonists Market Share by Application (2014-2019)
Figure Japan CXCR4 Antagonists Market Size 2014-2019 (Million US$)
Table Japan Key Players CXCR4 Antagonists Revenue (2018-2019) (Million US$)
Table Japan Key Players CXCR4 Antagonists Market Share (2018-2019)
Table Japan CXCR4 Antagonists Market Size by Type (2014-2019) (Million US$)
Table Japan CXCR4 Antagonists Market Share by Type (2014-2019)
Table Japan CXCR4 Antagonists Market Size by Application (2014-2019) (Million US$)
Table Japan CXCR4 Antagonists Market Share by Application (2014-2019)
Figure Southeast Asia CXCR4 Antagonists Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players CXCR4 Antagonists Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players CXCR4 Antagonists Market Share (2018-2019)
Table Southeast Asia CXCR4 Antagonists Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia CXCR4 Antagonists Market Share by Type (2014-2019)
Table Southeast Asia CXCR4 Antagonists Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia CXCR4 Antagonists Market Share by Application (2014-2019)
Figure India CXCR4 Antagonists Market Size 2014-2019 (Million US$)
Table India Key Players CXCR4 Antagonists Revenue (2018-2019) (Million US$)
Table India Key Players CXCR4 Antagonists Market Share (2018-2019)
Table India CXCR4 Antagonists Market Size by Type (2014-2019) (Million US$)
Table India CXCR4 Antagonists Market Share by Type (2014-2019)
Table India CXCR4 Antagonists Market Size by Application (2014-2019) (Million US$)
Table India CXCR4 Antagonists Market Share by Application (2014-2019)
Figure Central & South America CXCR4 Antagonists Market Size 2014-2019 (Million US$)
Table Central & South America Key Players CXCR4 Antagonists Revenue (2018-2019) (Million US$)
Table Central & South America Key Players CXCR4 Antagonists Market Share (2018-2019)
Table Central & South America CXCR4 Antagonists Market Size by Type (2014-2019) (Million US$)
Table Central & South America CXCR4 Antagonists Market Share by Type (2014-2019)
Table Central & South America CXCR4 Antagonists Market Size by Application (2014-2019) (Million US$)
Table Central & South America CXCR4 Antagonists Market Share by Application (2014-2019)
Table Sanofi Company Details
Table Sanofi Revenue in CXCR4 Antagonists Business (2014-2019) (Million US$)
Figure Sanofi Revenue Growth Rate in CXCR4 Antagonists Business (2014-2019)
Table Sanofi Recent Development
Table BioLineRx Company Details
Table BioLineRx Revenue in CXCR4 Antagonists Business (2014-2019)(Million US$)
Figure BioLineRx Revenue Growth Rate in CXCR4 Antagonists Business (2014-2019)
Table BioLineRx Recent Development
Table X4 Pharmaceuticals Company Details
Table X4 Pharmaceuticals Revenue in CXCR4 Antagonists Business (2014-2019)(Million US$)
Figure X4 Pharmaceuticals Revenue Growth Rate in CXCR4 Antagonists Business (2014-2019)
Table X4 Pharmaceuticals Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in CXCR4 Antagonists Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in CXCR4 Antagonists Business (2014-2019)
Table Eli Lilly Recent Development
Table Roche Company Details
Table Roche Revenue in CXCR4 Antagonists Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in CXCR4 Antagonists Business (2014-2019)
Table Roche Recent Development
Table Merck Company Details
Table Merck Revenue in CXCR4 Antagonists Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in CXCR4 Antagonists Business (2014-2019)
Table Merck Recent Development
Table Biokine Therapeutics Company Details
Table Biokine Therapeutics Revenue in CXCR4 Antagonists Business (2014-2019)(Million US$)
Figure Biokine Therapeutics Revenue Growth Rate in CXCR4 Antagonists Business (2014-2019)
Table Biokine Therapeutics Recent Development
Table GlycoMimetics Company Details
Table GlycoMimetics Revenue in CXCR4 Antagonists Business (2014-2019)(Million US$)
Figure GlycoMimetics Revenue Growth Rate in CXCR4 Antagonists Business (2014-2019)
Table GlycoMimetics Recent Development
Table Harmonic Pharma Company Details
Table Harmonic Pharma Revenue in CXCR4 Antagonists Business (2014-2019)(Million US$)
Figure Harmonic Pharma Revenue Growth Rate in CXCR4 Antagonists Business (2014-2019)
Table Harmonic Pharma Recent Development
Table Upsher-Smith Laboratories Company Details
Table Upsher-Smith Laboratories Revenue in CXCR4 Antagonists Business (2014-2019)(Million US$)
Figure Upsher-Smith Laboratories Revenue Growth Rate in CXCR4 Antagonists Business (2014-2019)
Table Upsher-Smith Laboratories Recent Development
Table Global CXCR4 Antagonists Market Size by Regions (Million US$) 2019-2025
Figure Global CXCR4 Antagonists Market Size Share by Regions (2019-2025)
Figure Global CXCR4 Antagonists Market Size Share by Regions in 2025
Figure United States CXCR4 Antagonists Market Size Forecast (2019-2025)(Million USD)
Figure Europe CXCR4 Antagonists Market Size Forecast (2019-2025)(Million USD)
Figure China CXCR4 Antagonists Market Size Forecast (2019-2025)(Million USD)
Figure Japan CXCR4 Antagonists Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia CXCR4 Antagonists Market Size Forecast (2019-2025)(Million USD)
Figure India CXCR4 Antagonists Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America CXCR4 Antagonists Market Size Forecast (2019-2025)(Million USD)
Table Global CXCR4 Antagonists Market Size by Product (2019-2025) (Million US$)
Figure Global CXCR4 Antagonists Market Size by Product (2019-2025)
Figure Global CXCR4 Antagonists Market Size by Product in 2025
Table Global CXCR4 Antagonists Market Size by Application (2019-2025) (Million US$)
Figure Global CXCR4 Antagonists Market Size by Application (2019-2025)
Figure Global CXCR4 Antagonists Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources